Ngenla is a medicine used to treat children and adolescents who are not growing at the normal rate as a result of growth hormone deficiency (lack of natural growth hormone). It is given to patients from 3 years of age. Ngenla contains the active substance somatrogon.
Therapeutic Indication
### Therapeutic indication Indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone
Therapeutic Area (MeSH)
ATC Code
H01AC08
ATC Item
somatrogon
Pharmacotherapeutic Group
PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| somatrogon | N/A | 索马特龙 |
EMA Name
Ngenla
Medicine Name
Ngenla
Aliases
N/A
